Subcutaneous immunoglobulin replacement for treatment of humoral immune dysfunction in patients with chronic lymphocytic leukemia

Subcutaneous immunoglobulin replacement for treatment of humoral immune dysfunction in patients with chronic lymphocytic leukemia

<h4>Background</h4> Patients with chronic lymphocytic leukemia (CLL) experience hypogammaglobinemia and non-neutropenic infections. In this exploratory proof of concept study, our objective was to determine the prevalence of humoral immunodeficiency in patients with CLL and serum IgG ≥ 4...

Full description

Bibliographic Details
Main Authors:	S. Shahzad Mustafa, Saad Jamshed, Karthik Vadamalai, Allison Ramsey
Format:	Article
Language:	English
Published:	Public Library of Science (PLoS) 2021-01-01
Series:	PLoS ONE
Online Access:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8519417/?tool=EBI

Similar Items

Immunoglobulin replacement in chronic lymphocytic leukaemia.
by: Bunch, C
Published: (1988)

Subcutaneous immunoglobulin replacement therapy: the European experience.
by: Chapel, H, et al.
Published: (2013)

Antibody deficiency secondary to chronic lymphocytic leukemia: Should patients be treated with prophylactic replacement immunoglobulin?
by: Dhalla, F, et al.
Published: (2014)

Antibody deficiency secondary to chronic lymphocytic leukemia: Should patients be treated with prophylactic replacement immunoglobulin?
by: Dhalla, F, et al.
Published: (2014)

P603: INFECTIONS BEFORE AND DURING IMMUNOGLOBULIN REPLACEMENT THERAPY IN PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA.
by: Christian Brieghel, et al.
Published: (2023-08-01)

Subcutaneous immunoglobulins in the treatment of chronic immune-mediated neuropathies
by: Verena I. Leussink, et al.
Published: (2016-07-01)

A Retrospective Study on the Efficacy of Subcutaneous Immunoglobulin as Compared to Intravenous Formulation in Patients with Chronic Lymphocytic Leukemia and Secondary Antibody Deficiency
by: Andrea Visentin, et al.
Published: (2022-12-01)

Immune Dysfunctions and Immune-Based Therapeutic Interventions in Chronic Lymphocytic Leukemia
by: Valentina Griggio, et al.
Published: (2020-11-01)

Intravenous immunoglobulin for the prevention of infection in chronic lymphocytic leukemia. A randomized, controlled clinical trial. Cooperative Group for the Study of Immunoglobulin in Chronic Lymphocytic Leukemia.
by: Gamm, H, et al.
Published: (1988)

Impact of Immune Parameters and Immune Dysfunctions on the Prognosis of Patients with Chronic Lymphocytic Leukemia
by: Candida Vitale, et al.
Published: (2021-07-01)

The comparison of the efficacy and safety of intravenous versus subcutaneous immunoglobulin replacement therapy
by: Bjorkander, J, et al.
Published: (2000)

Subcutaneous immunoglobulin replacement therapy in the treatment of patients with primary immunodeficiency disease
by: Suzanne Skoda-Smith, et al.
Published: (2009-12-01)

Systematic Evaluation of Antigenic Stimulation in Chronic Lymphocytic Leukemia: Humoral Immunity as Biomarkers for Disease Evolution
by: Alicia Landeira-Viñuela, et al.
Published: (2023-01-01)

Should treatment of hypogammaglobulinemia with immunoglobulin replacement therapy (IgRT) become standard of care in patients with chronic lymphocytic leukemia?
by: Alessandro Noto, et al.
Published: (2023-04-01)

Telomere Dysfunction in Chronic Lymphocytic Leukemia
by: Billy Michael Chelliah Jebaraj, et al.
Published: (2021-01-01)

Unravelling soluble immune checkpoints in chronic lymphocytic leukemia: Physiological immunomodulators or immune dysfunction
by: Alicia Landeira-Viñuela, et al.
Published: (2022-09-01)

Subcutaneous Leiomyosarcoma Metastasized to the Lymph Nodes Involved with Small Lymphocytic Lymphoma / Chronic Lymphocytic Leukemia
by: Ayfer KAMALI POLAT, et al.
Published: (2017-09-01)

Use of intravenous immunoglobulin in chronic lymphocytic leukemia. A brief review.
by: Dicato, M, et al.
Published: (1991)

Immunomodulatory effects of different intravenous immunoglobulin preparations in chronic lymphocytic leukemia
by: Ana Colado, et al.
Published: (2021-06-01)

Nanopore sequencing approach for immunoglobulin gene analysis in chronic lymphocytic leukemia
by: Crescenzio Francesco Minervini, et al.
Published: (2021-09-01)

Chronic Lymphocytic Leukemia-Induced Humoral Immunosuppression: A Systematic Review
by: Ewelina Grywalska, et al.
Published: (2020-11-01)

An updated perspective on immunoglobulin replacement in chronic lymphocytic leukaemia in the era of targeted therapies
by: Sujoy Khan, et al.
Published: (2023-04-01)

Immunoglobulin Gene Sequence as an Inherited and Acquired Risk Factor for Chronic Lymphocytic Leukemia
by: Moumita Datta, et al.
Published: (2022-06-01)

Immunoglobulin A nephropathy is characterized by anticommensal humoral immune responses
by: Elissa G. Currie, et al.
Published: (2022-03-01)

Expressions of immunoglobulin M and immunoglobulin D heavy chain in B-chronic lymphocytic leukemia and their correlation with CD38 expression
by: Ghid Nahd Abdul Muhssen, et al.
Published: (2017-01-01)

Immunoglobulin replacement in patients with chronic lymphocytic leukaemia: a comparison of two dose regimes.
by: Chapel, H, et al.
Published: (1994)

Intravenous Immunoglobulin Therapy-Induced Erythema Multiforme in a Patient with Chronic Lymphocytic Leukemia
by: Angelina Konovalova, et al.
Published: (2023-10-01)

Population pharmacokinetic and exposure–response analyses of intravenous and subcutaneous rituximab in patients with chronic lymphocytic leukemia
by: Ekaterina Gibiansky, et al.
Published: (2021-08-01)

Experience with subcutaneous immunoglobulin therapy in two pediatric cases of immune thrombocytopenia purpura
by: Chapdelaine H, et al.
Published: (2012-11-01)

Ten-year population trends of immunoglobulin use, burden of adult antibody deficiency and feasibility of subcutaneous immunoglobulin (SCIg) replacement in Hong Kong Chinese
by: Andy Ka Chun Kan, et al.
Published: (2022-12-01)

The repertoire of heavy chain immunoglobulin genes in B‑cell chronic lymphocytic leukemia in Russia and Belarus
by: B. V. Biderman, et al.
Published: (2014-07-01)

Somatic Mutation in Immunoglobulin Gene Variable Region in Patients with Chronic Lymphocytic Leukemia and Prognostic Impact
by: Mehrnoosh Pashaei, et al.
Published: (2017-02-01)

The repertoire of heavy chain immunoglobulin genes in B‑cell chronic lymphocytic leukemia in Russia and Belarus
by: B. V. Biderman, et al.
Published: (2014-07-01)

Consistent B Cell Receptor Immunoglobulin Features Between Siblings in Familial Chronic Lymphocytic Leukemia
by: P. Martijn Kolijn, et al.
Published: (2021-08-01)

Automated shape-based clustering of 3D immunoglobulin protein structures in chronic lymphocytic leukemia
by: Eleftheria Polychronidou, et al.
Published: (2018-11-01)

Recognizing acute promyelocytic leukemia in a patient with treated chronic lymphocytic leukemia
by: Suparna Nanua, et al.
Published: (2021-02-01)

Hyaluronidase facilitated subcutaneous immunoglobulin in primary immunodeficiency
by: Jolles S
Published: (2013-09-01)

Subcutaneous immunoglobulin replacement therapy in patients with immunodeficiencies – impact of drug packaging and administration method on patient reported outcomes
by: R. Mallick, et al.
Published: (2024-02-01)

Subcutaneous immunoglobulins replacement therapy in secondary antibody deficiencies: Real life evidence as compared to primary antibody deficiencies.
by: Francesco Cinetto, et al.
Published: (2021-01-01)

Distinct immune signatures in chronic lymphocytic leukemia and Richter syndrome
by: Yucai Wang, et al.
Published: (2021-05-01)